Detection of early prostate cancer using a hepsin-targeted imaging agent. - Wikidata - wikimedia - TriplyDB

Detection of early prostate cancer using a hepsin-targeted imaging agent.

Detection of early prostate cancer using a hepsin-targeted imaging agent.

http://www.wikidata.org/entity/Q33326514

about

Nanoparticle-facilitated functional and molecular imaging for the early detection of cancer Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics High-Throughput Approaches to the Development of Molecular Imaging Agents.Phage protein-targeted cancer nanomedicines.Techniques for molecular imaging probe design Targeted nanoagents for the detection of cancers Combinatorial peptide libraries: mining for cell-binding peptides.Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.Phage display in molecular imaging and diagnosis of cancer.Phage display and molecular imaging: expanding fields of vision in living subjects.Enabling individualized therapy through nanotechnology Applications of molecular MRI and optical imaging in cancer.A fluorescent protein scaffold for presenting structurally constrained peptides provides an effective screening system to identify high affinity target-binding peptides.Optical contrast agents and imaging systems for detection and diagnosis of cancer.Inorganic nanoparticle-based contrast agents for molecular imaging Active targeting of mesoporous silica drug carriers enhances γ-secretase inhibitor efficacy in an in vivo model for breast cancer.Matrix-dependent regulation of AKT in Hepsin-overexpressing PC3 prostate cancer cells.Imaging virus-associated cancer.Regulators of gene expression as biomarkers for prostate cancer Multimodal iron oxide nanoparticles for hybrid biomedical imaging.M13 bacteriophage display framework that allows sortase-mediated modification of surface-accessible phage proteins A Hybrid Peptide PTS that Facilitates Transmembrane Delivery and Its Application for the Rapid In vivo Imaging via Near-Infrared Fluorescence Imaging.Type II transmembrane serine proteases as potential targets for cancer therapy.Multifunctional magnetic nanoparticles for targeted imaging and therapy Molecular imaging of prostate cancer: a concise synopsis Prostate cancer: the need for biomarkers and new therapeutic targets.Targeted hyperthermia using metal nanoparticles.Putative molecular signatures for the imaging of prostate cancer.Peptide-mediated cancer targeting of nanoconjugates.The evolution of imaging in cancer: current state and future challenges.The use of molecular imaging of gene expression by radiotracers in gene therapy.Practical theoretic guidance for the design of tumor-targeting agents.Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands.Synthesis and in vitro evaluation of MR molecular imaging probes using J591 mAb-conjugated SPIONs for specific detection of prostate cancer.Use of two gene panels for prostate cancer diagnosis and patient risk stratification.Synthesis of bombesin-functionalized iron oxide nanoparticles and their specific uptake in prostate cancer cells.Molecular magnetic resonance imaging approaches used to aid in the understanding of the tissue regeneration marker Met in vivo: implications for tissue engineering.RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells.

P2860

Q26828849-9A27B6BC-3759-446F-9CA2-1075243A13DD Q26829059-0A93755F-BADC-4EBE-A538-CA222E3B0D12 Q30275493-DC2D14CA-5C8E-4520-9DE6-52C68DE15C1D Q30403553-E3D15A96-7DAE-464E-BB75-7E1EE509DE7D Q30423734-3AF1564B-A18D-4884-AB76-8F8BD62C1A40 Q30472641-245A3FD2-93F6-46AF-86DB-0DC89B613C15 Q31144876-97A8CB94-4959-4C0C-A08D-E271314CF1FC Q33520512-98CAB8ED-42FD-49F8-9FA2-A56DF233FD48 Q33532734-3128426E-7C18-4FCB-907B-72EC4D1EE061 Q33849788-1C54B46F-D7C1-4E26-B70E-B65689768EF4 Q33917755-11F6645D-FD16-46B3-9AD7-E77F6CD6E403 Q33986159-272BBD13-327A-4F10-B20F-C331E3F81ECB Q33989074-2C378535-8E1B-4FB2-AC4A-981851CDF5B0 Q33989090-4974A9BC-3AF1-4FC5-90B4-E6828E120F5D Q34644628-5E886960-8ECB-4293-A4C4-661A7EC0D8AE Q34881011-9A25ADBE-F9D2-43D0-BB91-F6ABAD33AE0E Q35095228-6FFC871D-D447-4308-A1BC-1C5206DAAD26 Q36015054-875B2C51-B145-4E0D-8895-6890A40E5860 Q36439912-D65D0F1C-32BC-4EE2-B197-21B2D552D110 Q36545276-10AFC2A2-FAFF-4ECA-BD17-4B6123D6C039 Q36588148-B1CB9B92-8F54-4783-8A9A-6B72C6DA0D09 Q36661758-ED84EFC7-E3A1-4996-9B37-CD322A943F9B Q37168351-DBF55316-11D7-421C-A717-B94D04EA1891 Q37174947-713ECBDA-CE99-4F25-A322-827F9119906E Q37207397-3CAB5874-7BAD-4A8D-8A51-7CD5671925D0 Q37476043-DAA9CE67-FB06-4ED2-A5CA-7850822B7694 Q37631871-80F40CEF-AEB1-46EB-BACC-945ECBD00AF6 Q37656266-BBD374C4-7E41-4333-BF85-ECD87074E2C0 Q37806710-153CA38F-A5BA-4755-813D-B2798B469550 Q37848518-EC9CCD57-F1E8-49D6-B912-B5F4EE9159B5 Q37884052-5461EDF2-FC74-43B5-B21C-CB72079BC58F Q38644304-6F80C999-BA17-4DFB-9CB5-B0AC1A777532 Q38774550-9DBBFA86-5844-49FA-B92B-FC536C8BB663 Q39217780-4D570DA1-0CB4-4BE7-A7C6-3063DD439F30 Q40945727-9E54EE8D-37E1-45F4-A258-4D4B243F73BC Q40994215-4352719D-EF57-44BC-99B6-296BC6481C3E Q41847796-9129AECB-72AA-4087-B2D7-ABE85807A8C9 Q55208940-7E8AE009-66E1-4C5D-8756-123CFA933623

P2860

Detection of early prostate cancer using a hepsin-targeted imaging agent.

http://www.wikidata.org/entity/Q33326514

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Detection of early prostate cancer using a hepsin-targeted imaging agent.

@ast

Detection of early prostate cancer using a hepsin-targeted imaging agent.

@en

Detection of early prostate cancer using a hepsin-targeted imaging agent.

@nl

type

label

Detection of early prostate cancer using a hepsin-targeted imaging agent.

@ast

Detection of early prostate cancer using a hepsin-targeted imaging agent.

@en

Detection of early prostate cancer using a hepsin-targeted imaging agent.

@nl

prefLabel

Detection of early prostate cancer using a hepsin-targeted imaging agent.

@ast

Detection of early prostate cancer using a hepsin-targeted imaging agent.

@en

Detection of early prostate cancer using a hepsin-targeted imaging agent.

@nl

P1433

Q33326514-F148F01F-3EA4-4049-92E7-8F0B3A6754A2

P1476

Q33326514-DA72427D-B264-424D-8F33-1F58735A5B33

P2093

Q33326514-750987DC-7979-4322-BEF4-ED0A126AC515

Q33326514-A31538A3-F97C-461C-8EF0-3B0BFACADBF8

Q33326514-BCAC4DFB-EE31-4B76-B42F-973AAD61C922

Q33326514-BE7990F0-3EB2-4D93-9796-7EB6F4D9893A

Q33326514-FF54D578-145F-44EC-A1AC-36A4E37C61BA

P2860

Q33326514-12C41897-EED7-4264-832C-441A70680172

Q33326514-25886E15-9CE4-4984-9501-6C1995821FBD

Q33326514-259A21B4-7A0F-49B8-BAA0-1A1AE64914AF

Q33326514-2AAB9FDB-F21B-4C1D-9F12-1488E3E9FE1B

Q33326514-301872E9-6CC1-463D-B669-216C77669938

Q33326514-4930955A-EC4C-4F69-A3BE-1448A8F9515B

Q33326514-50848988-F538-42DE-9E6E-C3B352AD3103

Q33326514-742A5D81-2DBD-46A4-96AD-6EB6B61A6A98

Q33326514-7FA9F18D-2DD7-4314-889C-25263ED9FEFF

Q33326514-8D60867C-0AED-4CC8-88CA-399854A65833

P304

Q33326514-4D8065E2-156E-4681-BD4F-24F49CD86532

P31

Q33326514-F6236240-EE52-4C0E-A641-2B43866D3FE6

P356

Q33326514-C2F2AD0C-94A5-46CD-AD59-E9E47B31977F

P407

Q33326514-06CAE0EC-876A-4198-A592-000D7637120C

P433

Q33326514-BE2856FF-822A-4B95-B11E-95DBA9AD354F

P478

Q33326514-BD2C8705-0A97-4FFC-A28D-0165A9BFEC5E

P50

Q33326514-5BEB1359-AF9D-462C-84DA-B033D522A20E

Q33326514-5EE1A55F-289C-4D0C-AFB2-2E9CEB2FCA0E

P577

Q33326514-05AC0FE9-D14F-4B8F-A19F-083C63C71BF4

P5875

Q33326514-582BA8BD-7FC8-4636-BFEC-0F10507727B2

P698

Q33326514-B7DE7746-79FD-4DF5-85DE-146963C64FBB

P932

Q33326514-44F3907C-7A22-43C5-96D3-4504B94BC559

P356

0008-5472.CAN-07-1349

P1433

Cancer Research

P1476

Detection of early prostate cancer using a hepsin-targeted imaging agent.

@en

P2093

Kimberly A Kelly

http://www.w3.org/2001/XMLSchema#string

Peter Waterman

http://www.w3.org/2001/XMLSchema#string

Rajesh Anbazhagan

http://www.w3.org/2001/XMLSchema#string

Robert Ross

http://www.w3.org/2001/XMLSchema#string

Sunita R Setlur

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2007

Multiclass cancer diagnosis using tumor gene expression signatures

Delineation of prognostic biomarkers in prostate cancer

Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle.

Isolation of a colon tumor specific binding peptide using phage display selection.

Prostate specific antigen: a decade of discovery--what we have learned and where we are going.

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Radical prostatectomy versus watchful waiting in early prostate cancer.

P304

2286-2291

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-07-1349

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

Ralph Weissleder

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5472097

http://www.w3.org/2001/XMLSchema#string

P698

18381435

http://www.w3.org/2001/XMLSchema#string

P932

2709884

http://www.w3.org/2001/XMLSchema#string